Board of Directors
Company Risk
The aesthetic surgery and beauty services industry is highly competitive, with competition arising from both existing operators with established customer bases and new entrants continuously entering the market. This has led to intensified competition in marketing, branding, and pricing strategies in order to effectively reach and respond to target customer segments. Nevertheless, the industry continues to demonstrate steady growth, as Thai society has become more open to aesthetic procedures and beauty treatments. At the same time, consumers increasingly place importance on their physical appearance, both for social purposes and career opportunities. This has resulted in a continuous increase in demand for aesthetic surgery and skincare services. However, such growth in demand has attracted a significant number of new entrants into the market, further intensifying industry competition, which may have a material impact on the Company’s operating performance in the long term.
The Company places the highest importance on the quality and standards of its services as its core priority. It is led by Asst.Prof.Dr.Choladhis Sinrachtanant, a highly skilled and widely recognized specialist in aesthetic procedures with a long-standing reputation in the cosmetic surgery industry. He plays a key role in advancing the Company’s medical knowledge and innovation. Asst.Prof.Dr.Choladhis Sinrachtanant has been instrumental in developing and introducing new techniques in various procedures, such as short-incision double eyelid surgery and autologous fat grafting for rhinoplasty. He also continuously transfers his knowledge and expertise to the medical team at Teeraporn Hospital, provides guidance during procedures, and conducts post-treatment evaluations to ensure that all services meet the Company’s established standards. In addition, the Company has appointed medical advisors to assess and provide recommendations to every patient prior to treatment. This includes evaluating each individual’s readiness and unique characteristics, as well as recommending the most appropriate treatment techniques to ensure outcomes that align with the patient’s facial structure and expectations, thereby enhancing satisfaction and confidence in the results. Currently, Cdr. Suwannee Jirayangyuen, the Company’s founder and major shareholder, serves as the principal medical advisor in this role. With a service approach that emphasizes quality at every stage from consultation through post-treatment follow-up the Company has consistently achieved high levels of customer satisfaction. This enables the Company to retain its existing customer base while expanding new customers through word-of-mouth referrals, thereby reducing pricing pressures within the industry. The Company’s continued strong growth in operating performance over recent years further reflects its capability to adapt and compete effectively in a highly competitive industry.
Currently, the production of doctors and medical personnel is insufficient to meet the growing demand from both domestic and international clients seeking cosmetic surgery. The increase in the number of industry players has intensified the demand for medical professionals, who require considerable time to develop their skills and expertise. If the company is unable to recruit or develop a team of specialized doctors and medical staff in a timely manner, there may be risks associated with a shortage of medical personnel, which could impact the company's operations.
Historically, the Company has not experienced any shortage of physicians or medical personnel. Nevertheless, the Company recognizes the importance of its medical professionals and continuously promotes their development and capability enhancement. This includes strengthening physicians’ competencies to perform a wide range of surgical procedures, encouraging the exchange of surgical techniques, and providing opportunities for knowledge sharing and case discussions among medical teams, as well as ongoing training programs to continuously build expertise among physicians and medical personnel. In addition, the Company fosters strong organizational values that promote unity and collaboration among personnel, while cultivating a positive working environment to enhance employee motivation. The Company also maintains fair and competitive compensation policies. Furthermore, the reputation of Teeraporn Hospital serves as an additional factor in attracting highly qualified physicians and medical professionals to join the organization. Accordingly, the Company is confident that these approaches will effectively mitigate the risk of shortages of physicians and medical personnel.
If the Company is unable to keep pace with or adapt to such trends in a timely manner, it may lose business opportunities in both attracting new customers and retaining its existing customer base, which could adversely affect the Company’s revenue and operating performance in the long term.
The Company places strong emphasis on continuously studying and analyzing consumer behavior. It has established dedicated teams to monitor trends, market preferences, technologies, and innovations in aesthetic procedures, as well as to conduct customer satisfaction surveys. The insights obtained are analyzed and utilized in formulating marketing strategies and enhancing service delivery to effectively and timely meet customer needs. The Company believes that such an approach will strengthen its competitiveness and support sustainable long-term business growth.
Customers recognize the Teeraporn Hospital brand because of Assistant Professor Dr. Choladhis Sinrachtanant. However, this also creates a risk for the company, as it becomes dependent on a key executive for its recognition and reputation.
The Company recognizes the potential risks and has therefore implemented the following risk mitigation measures: - The Company has established an adequate and effective internal control system in accordance with the criteria prescribed by the Capital Market Supervisory Board. It has also defined a clear organizational structure, including the composition, scope, authority, duties, and responsibilities of each function. - In recent years, the Company has leveraged online communication and advertising channels by emphasizing the brand identity of “Teeraporn Hospital by Medical Team,” thereby reducing reliance on Asst.Prof.Dr.Choladhis Sinrachtanant. The Company has increased the visibility of its medical team in media appearances and marketing materials, including featuring physicians in artwork and highlighting their names to enhance brand recognition among customers. - The Company has implemented a succession plan to ensure effective personnel management, appropriate delegation of authority, and mitigation of related risks. In addition, most of the Company’s physicians and executives have long tenure with the organization, providing them with extensive experience and deep understanding of the business. The Company also conducts regular training for both medical teams and executives, supporting systematic operations and future growth. - The Company has established a retirement policy, with retirement age set at 70 years for executives and 60 years for other employees. However, Asst.Prof.Dr.Choladhis Sinrachtanant, the Chief Executive Officer, is exempt from the retirement age. Furthermore, experienced executives remain committed to their roles and have plans to develop successors in accordance with the Company’s succession plan, ensuring continuity in leadership after retirement.
As the company operates in the cosmetic surgery business, it places a strong emphasis on providing high-quality treatments that meet customer satisfaction. Each customer has different expectations regarding the outcomes, and the results of procedures depend on individual skin conditions. If the outcomes of the procedures do not meet the customers' expectations and fail to satisfy them, it may lead to criticism on social media, complaints to relevant authorities, and even legal actions. This could impact the company's reputation and overall performance.
The company places great importance on customer satisfaction, starting from the selection process of doctors to ensure that they have the necessary skills for performing procedures. The company also continuously develops its in-house doctors to enhance their surgical expertise and ensure they are capable of delivering high-quality results that meet customer needs. Additionally, the company has established a risk management task force to assess and monitor customer satisfaction and improve operational efficiency, which also serves as a preventive measure to minimize the risk of lawsuits. Furthermore, the company offers a one-year post-surgery result guarantee. Before any procedure, customers are required to sign a consent form, which states: "I am aware that all medical procedures, including surgeries, may have unforeseen circumstances, and the results may not always be as expected. If corrective surgery or treatment is required, although medical practice allows for additional charges, I have received confirmation from the surgeon that no additional charges will be made within one year." The company is responsible for all related expenses. To prevent any unforeseen events from leading to legal action that could affect the doctor, the company requires all its doctors to take out Medical Malpractice Insurance to reduce the risk of costs arising from lawsuits. As of December 31, 2025, the company has not faced any lawsuits for damages related to healthcare services that would affect the company's operations.
If the Company fails to fully comply with applicable laws, regulations, and requirements governing healthcare facility operations, it may be subject to penalties imposed by regulatory authorities, such as warnings, fines, suspension, or revocation of its operating licenses. This could directly affect the continuity of the Company’s business operations. In addition, non-compliance may adversely impact service standards, customer confidence, and the Company’s reputation and corporate image. This could lead to a loss of business opportunities and negatively affect the Company’s revenue and operating performance in the long term.
The Company recognizes the importance of compliance with applicable laws, regulations, rules, and requirements. Accordingly, the Company places strong emphasis on adhering to all relevant regulatory and legal frameworks. The Company has established policies requiring its personnel to continuously monitor and review regulatory developments, as well as to participate in training programs and seminars in order to stay informed of updates and information from relevant government authorities concerning healthcare operations. This ensures that the Company is able to comply accurately and effectively with all applicable laws, regulations, and requirements.
Shareholder Risk
Minority shareholders may not be able to gather sufficient votes to scrutinize or counterbalance proposals put forth by the major shareholders.
The company's board structure consists of independent directors making up at least one-third of the total board members. The chairman of the board is an independent director, and independent directors also serve on the audit committee to oversee the company's operations and ensure that all actions are conducted in the company's best interests. Additionally, the company has established clear and transparent scopes of operations, duties, and responsibilities, as well as the delegation of authority to directors and executives. Measures have been implemented to regulate related-party transactions involving directors, major shareholders, controlling persons, and individuals with conflicts of interest. These individuals are not permitted to vote on the approval of such transactions, ensuring transparency and the company’s best interests in all business operations.
Unlock full benchmarking
Claim this company to see every KPI your sector qualifies for, from 70+ across the market, benchmarked against sector peers.

